Treating Acute Leukemias: Blood Cancer United-NMDP Project ECHO series
On-demand webinar series for hematology/oncology professionals
The Project ECHO model is designed to create a shared learning space for health care professionals through a series of three educational sessions, fostering peer engagement and disseminating best practices in community care. Rapid advances in the treatment of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), can make treatment decisions challenging.
This virtual series will help providers stay up to date on the latest in disease-specific indications, treatment with hematopoietic cell transplant (HCT) and cell therapy, and post-treatment monitoring and care coordination to improve patient outcomes.
Access the on-demand Treating Acute Leukemias sessions
Rapid Diagnosis, Risk Stratification and Induction Therapies
Session 1 learning objectives
After completing this activity, the participant should be better able to:
- Describe disease-specific features and indications of acute leukemias, including subtype classification
- Identify tests used to diagnose acute leukemias
- Examine therapeutic options for induction
Evolving Treatment in Cell Therapy and Transplant
Session 2 learning objectives
After completing this activity, the participant should be better able to:
- Examine the appropriate treatments for acute leukemias and timing, including allogeneic HCT and CAR T-cell therapy
- Identify and manage treatment related side effects and treatment related complications
Coordinated Care from Treatment to Survivorship
Session 3 learning objectives
After completing this activity, the participant should be better able to:
- Discuss post-treatment monitoring of long-term and late effects and surveillance strategies for detecting relapse post allogeneic HCT and CAR T-cell therapy
- Identify best practices in care coordination between hematology/oncology, transplant and other providers involved in the care of patients
Target audience
This activity is intended for hematology/oncology providers, including physicians, advanced practice professionals and nurses who want to learn more about managing, treating and monitoring patients with acute leukemias including those undergoing transplant and cell therapy.
Faculty
Session 1
Alice S. Mims, MD, MSCR
Acute Leukemia Research Section Head
Associate Division Director Clinical Research
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Courtney Bellomo, MD
Hematology
New York Oncology Hematology
Albany, N.Y.
Meghan McGrath, MSN, RN, AGACNP-BC
Clinical Trial Nurse Navigator
Blood Cancer United
Washington, D.C.
Session 2
Alice S. Mims, MD, MSCR
Acute Leukemia Research Section Head
Associate Division Director Clinical Research
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Clark Alsfeld, MD
Hematologist/Oncologist
Ochsner MD Anderson Cancer Center
Ochsner Health
Darci Zblewski, APN, C-NP
Consultant
Blood Cancer United
Washington, D.C.
Session 3
Clark Alsfeld, MD
Hematologist/Oncologist
Ochsner MD Anderson Cancer Center
Ochsner Health
Courtney Bellomo, MD
Hematology
New York Oncology Hematology
Albany, N.Y.
Ankita Shah, FNP-BC
Nurse Practitioner
Access Partnership Consultant
NMDPSM
All sessions
Alison Loren, MD, MSCE (chair/moderator)
Chief, Division of Hematology/Oncology
Director, Blood and Marrow Transplantation
C. Willard Robinson Professor of Hematology/Oncology
University of Pennsylvania
Philadelphia, Pa.
Shernan Holtan, MD (chair/moderator)
Chief, Blood and Marrow Transplantation Section
Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, N.Y.
This activity is provided by Blood Cancer United, NMDP, the Medical Learning Institute Inc. and Project ECHO.
